Cue Biopharma Inc expected to post a loss of 14 cents a share - Earnings Preview
09/08/2025 24:40
Cue Biopharma Inc CUE.OQ CUE.O is expected to show a fall in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025 The Boston Massachusetts-based company is expected to report a 9.9% decrease in revenue to $2.396 million from $2.66 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data. LSEG's mean analyst estimate for Cue Biopharma Inc is for a loss of 14 cents per share. The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Cue Biopharma Inc is $4.00, about 79.2% above its last closing price of $0.83 This summary was machine generated August 8 at 23:40 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)